CD3 antigen modulation in T-lymphocytes during OKT3 treatment.
Magnussen
K
K
Department of Clinical Immunology, University Hospital of Aarhus, Skejby Sygehus, Denmark.
Klug
B
B
Møller
B
B
D017252:CD3 Complex / Q000187:drug effects / Q000378:metabolism*; D005434:Flow Cytometry / Q000379:methods; D016650:Fluorescein-5-isothiocyanate; D006084:Graft Rejection / Q000276:immunology / Q000628:therapy*; D006801:Humans; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology*
D017252:CD3 Complex; D016853:Muromonab-CD3; D016650:Fluorescein-5-isothiocyanate